1De Jaeger K, Seppenwoolde Y, Boersma LJ, et al. Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2003, 55 : 1331-1340.
2Robnett TJ, Maehtay M, Vines EF, et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer, Int J Radiat Oncol Biol Phys, 2000, 48:89-94.
3Giordano A, Calcagni ML, Meduri G, et al. Perfusion lung scintigraphy for the prediction of posflobectomy residual pulmonary function. Chest, 1997, 111:1542-1547.
4Bolliger CT, Wyser C, Roser H, et al. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications. Chest,1995,108:341-348.
5Theuws JC, Kwa SL, Wagenaar AC, et al. Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother Oncol, 1998,49:233-243.
6Boersma LJ, Damen EM, de Boer RW, et al. Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma. Radiother Oncol, 1994, 32:201-209.
7Abratt RP, Willcox PA, Smith JA. Lung cancer in patients with borderline lung functions: zonal lung perfusion scans at presentation and lung function after high dose irradiation. Radiother Oncol,1990, 19:317-322.
8Marks LB, Spencer DP, Bentel GC, et al. The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation. Int J Radiat Oncol Biol Phys,1993, 26:659-668.
9Seppenwoolde Y, Engelsman M, De Jaeger K, et al. Optimizing radiation treatment plans for lung cancer using lung perfusion information. Radiother Oncol, 2002, 63 : 165-177.
